
|Articles|April 9, 2017
Biosimilar Trends Highlight AJPB Week in Review
Author(s)AJPB staff
Top articles of the week from The American Journal of Pharmacy Benefits.
Advertisement
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Reformulated Ranitidine After 5-Year Absence
2
Gluteus Maximus Muscle Shape Changes Tied to Aging, Frailty, and Type 2 Diabetes
3
Durvalumab Receives FDA Approval for Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
4
FDA Approves Sibeprenlimab for Patients with IgAN
5

















































































































































































































